13F-HR filed by Ishara Investments LP
Ishara Investments LP filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 15:11:09 UTC, with 41 holding rows worth $121,006,810.
- Accession
- 0002111609-26-000005
- Filer
- CIK 2111609
- Filed
- 2026-11-16
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
13F report for Q3 2026
A holdings report, 41 entries on the cover page, a total value of $121,006,810 stated on the cover page (in dollars after the unit check, H1), rows summing to $121,006,810 with VALUE read as dollars as filed, 13F file number 028-26490. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 145,000 | $8,537,600 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 128,000 | $8,436,480 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 100,000 | $6,580,000 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 320,000 | $6,448,000 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 70,000 | $5,502,700 | dollars as filed | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 80,000 | $5,182,400 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 17,000 | $4,950,910 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 150,000 | $4,843,500 | dollars as filed | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 180,000 | $4,757,400 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 1,120,000 | $4,737,600 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 8,000 | $4,335,120 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 160,000 | $3,891,200 | dollars as filed | |
| XERIS BIOPHARMA HOLDINGS INC | 98422E103 | COM | 400,000 | $3,824,000 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 48,000 | $3,816,960 | dollars as filed | |
| DBV TECHNOLOGIES S A | 23306J309 | SPONSORED ADS | 270,000 | $3,175,200 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 150,000 | $3,088,500 | dollars as filed | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 1,080,000 | $2,991,600 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 48,000 | $2,880,000 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 12,000 | $2,710,560 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 100,000 | $2,513,000 | dollars as filed | |
| LIGAND PHARMACEUTICALS INC | 53220K504 | COM NEW | 8,000 | $2,498,960 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 160,000 | $2,404,800 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 40,000 | $2,276,000 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 160,000 | $2,155,200 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 10,000 | $1,843,900 | dollars as filed | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 160,000 | $1,748,800 | dollars as filed | |
| BEAM THERAPEUTICS INC | 07373V105 | COM | 70,000 | $1,711,500 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 120,000 | $1,602,000 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 1,000 | $1,503,000 | dollars as filed | put |
| CONTINEUM THERAPEUTICS INC CL A | 21217B100 | Stock | 108,000 | $1,449,360 | dollars as filed | |
| GENMAB A/S | 372303206 | Ordinary Shares, nominal value DKK 1 per share | 40,000 | $1,427,000 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 8,000 | $1,134,720 | dollars as filed | |
| MONOPAR THERAPEUTICS INC | 61023L207 | COMMON STOCK | 12,000 | $956,040 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 80,000 | $936,000 | dollars as filed | |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 200,000 | $862,000 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 16,000 | $714,400 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 80,000 | $691,200 | dollars as filed | |
| LEXICON PHARMACEUTICALS INC | 528872302 | COMMON STOCK | 320,000 | $600,000 | dollars as filed | |
| Wave Life Sciences Inc. | 94352A104 | COM | 160,000 | $592,000 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 80,000 | $412,800 | dollars as filed | |
| Gossamer Bio, Inc. | 38341P201 | Common Stock, $0.0001 par value per share | 24,000 | $284,400 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0002111609-26-000005 | this filing | 2026-11-16 |